6a,3'-p-Dihydroxy paclitaxel
CAS: 157230-10-9
Ref. 3D-FD22062
25µg | Discontinued | ||
50µg | Discontinued | ||
100µg | Discontinued | ||
250µg | Discontinued | ||
500µg | Discontinued |
Product Information
- (2alpha,5beta,6alpha,7beta,10beta,13alpha)-4,10-bis(acetyloxy)-13-{[(2R,3S)-3-(benzoylamino)-2-hydroxy-3-(4-hydroxyphenyl)propanoyl]oxy}-1,6,7-trihydroxy-9-oxo-5,20-epoxytax-11-en-2-yl benzoate
- 6α,3′-p-Dihydroxypaclitaxel
- 7,11-Methano-1H-cyclodeca[3,4]benz[1,2-b]oxete, benzenepropanoic acid deriv.
- Benzenepropanoic acid, beta-(benzoylamino)-alpha,4-dihydroxy-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-3,4,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca(3,4)benz(1,2-b)oxet-9-yl ester, (2aR-(2aalpha,3alpha,4beta,4abeta,6beta,
- Benzenepropanoic acid, β-(benzoylamino)-α,4-dihydroxy-, (2aR,3S,4R,4aS,6R,9S,11S,12S,12aR,12bS)-6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-3,4,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, (αR,βS)-
- Benzenepropanoic acid, β-(benzoylamino)-α,4-dihydroxy-, 6,12b-bis(acetyloxy)-12-(benzoyloxy)-2a,3,4,4a,5,6,9,10,11,12,12a,12b-dodecahydro-3,4,11-trihydroxy-4a,8,13,13-tetramethyl-5-oxo-7,11-methano-1H-cyclodeca[3,4]benz[1,2-b]oxet-9-yl ester, [2aR-[2aα,3α,4β,4aβ,6β,9α(αR*,βS*),11α,12α,12aα,12bα]]-
- 6,3'-p-Dihydroxypaclitaxel
6a,3'-p-Dihydroxy paclitaxel is a molecule that has anticancer activity. It binds to the tumor cell membrane and inhibits the protein-mediated efflux of paclitaxel out of the cell. 6a,3'-P-Dihydroxy paclitaxel has been shown to be effective against human ovarian carcinoma cells in vitro and in vivo. This drug also has anti-inflammatory properties and may be useful for treating arthritis.